Skip to main content

Use of Taurine During Rehabilitation After Cardiac Surgery

  • Conference paper
Taurine 9

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 803))

Abstract

The increasing availability of high-technology care, such as cardiac surgery, raises questions regarding patients’ rehabilitation in the post-surgical period. Recently, the development and maintenance of Centers for Cardiac Surgery all over the Russian Federation has been a major focus of medical community. However, less attention has been directed toward the issue of post-surgical rehabilitation.

The search for new pharmaceutical agents and methods of rehabilitation is a promising direction for the development of rehabilitation medicine. The present study reports the potential use of taurine during the recovery period following coronary bypass surgery or heart valve replacement surgery.

In patients undergoing heart valve replacement and coronary bypass surgery, the use of taurine results in an increase in left ventricular ejection fraction and a reduction in left ventricular myocardial mass index and triglyceride levels. The quality of life improved significantly. The results of “WAM” testing demonstrated the improved parameters of Well-being, Activity and Mood in the patients enrolled into the Taurine arm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AH:

Arterial hypertension

BID:

“Bis in die” twice a day

BP:

Blood pressure

CH:

Concentric hypertrophy

CHD:

Coronary heart disease

CHF:

Chronic heart failure

CI:

Cardiac index

CR:

Concentric remodelling

ECG:

Electrocardiogram

EDD:

End-diastolic diameters

EDV:

End-diastolic volumes

EF:

Ejection fraction

EH:

Eccentric hypertrophy

ESD:

End-systolic diameters

ESV:

End-systolic volumes

HDL-C:

High-density lipoprotein cholesterol

HR:

Heart rate

IVST:

Inter-ventricular septum thickness

LDL-C:

Low-density lipoprotein cholesterol

LVEF:

Left ventricular ejection fraction

LVMM:

Left ventricular myocardial mass

LVPW:

Left ventricle posterior wall thickness

NG:

Normal geometry

NYHA:

New York heart association

RWT:

Relative walls thickness

SI:

Systolic index

SV:

Systolic volume

QoL:

Quality of life

TG:

Triglyceride

WAM:

Well-being, activities and mood

References

  • Mareev V, Ageev F, Arutynov A et al. (2003) National guideline on the diagnosis and treatment of CHF. J “Serdechnaya Nedostatochnost” 4(6):276–297

    Google Scholar 

  • Doddakula KK, Neary PM, Wang JH, Sookhai S, O’Donnell A, Aherne T, Bouchier-Hayes DJ, Redmond HP (2010) The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine. Surgery 148(3):567–572

    Article  PubMed  Google Scholar 

  • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. (2006) A report from the American society of echocardiography’s guidelines and standards committee and the camber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108

    Google Scholar 

  • Sahin MA, Yucel O, Guler A, Doganci S, Jahollari A, Cingoz F, Arslan S, Gamsizkan M, Yaman H, Demirkilic U (2011) Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia? J Cardiothorac Surg 6:31

    Article  PubMed  PubMed Central  Google Scholar 

  • Suleiman MS, Fernando HC, Dihmis WC, Hutter JA, Chapman RA (1993) A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery. Br Heart J 69(3):241–245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evgeny Averin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this paper

Cite this paper

Averin, E. (2015). Use of Taurine During Rehabilitation After Cardiac Surgery. In: Marcinkiewicz, J., Schaffer, S. (eds) Taurine 9. Advances in Experimental Medicine and Biology, vol 803. Springer, Cham. https://doi.org/10.1007/978-3-319-15126-7_51

Download citation

Publish with us

Policies and ethics